The overall incidence of life-threatening invasive fungal infections has increased during the past several decades because, in part, of an increasing population of immunosuppressed and critically ill patients. Patients with cancer with chemotherapy-induced neutropenia, transplant recipients receiving immunosuppressive therapy, patients with HIV, and patients in ICUs are at an increased risk of acquiring fungal infections. Healthcare professionals need to educate vulnerable patients about the importance of infection-control protocols to reduce their risk of developing invasive fungal infections. Such patient education can save lives. This module fills gaps in knowledge about the prevention of life-threatening fungal infections. This module also provides information regarding the newer, deadly, globally-emerging pathogen, Candida auris.
In support of improving patient care, Relias LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
In support of improving patient care, Relias LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Arkansas State Board Of Nursing Approved Continuing Education program (CEBroker Provider #50-290).
District of Columbia Board of Nursing Approved Continuing Education program (CEBroker Provider #50-290).
Florida Board of Medicine (CEBroker Provider #50-290)
Physicians will receive 0.50 AMA PRA category 1 Credits™.
Georgia Board of Nursing (CEBroker Provider #50-290)
Kentucky Board of Nursing (CEBroker Provider #50-290)
Nurses will receive 0.50 contact hours for participating in this course.
Louisiana State Board of Medical Examiners (CEBroker Provider #: 50-290)
Mississippi Board of Nursing (CEBroker Provider #50-290)
Mississippi State Board of Medical Licensure (CEBroker Provider #: 50-290)
New Mexico Board of Nursing (CEBroker Provider #50-290)
Physicians will receive 0.50 AMA PRA category 1 Credits™.
North Dakota Board of Nursing (CEBroker Provider #50-290)
State Medical Board of Ohio (CEBroker Provider #: 50-290)
South Carolina Board of Medical Examiners (CEBroker Provider #50-290)
South Carolina Board of Nursing (CEBroker Provider #50-290)
Tennessee Board of Medical Examiners (CEBroker Provider #50-290)>
Physicians will receive 0.50 AMA PRA category 1 Credits™
Outline:
Section 1: Introduction
About This Course
Learning Objectives
Section 2: Life-Threatening Fungal Infections
Introduction
How Candida Gets a Foothold
A New Threat
Aspergillus All Around Us
Elusive Clues
Treatment Should Not Wait
Healthcare Professionals Lead Prevention Efforts
Section 3: Review Questions
Review
Section 4: Conclusion
Course Summary
Course Contributors
References
Barbara Barzoloski-O'Connor is the Director of Infection Prevention and Control at Northwest Hospital, Lifebridge Health in Randallstown, Maryland.Instructor: Paul Teelin, MSN, RN-BC
Paul Teelin, MSN, RN-BC is a SME writer with Relias. Paul has a varied, multidisciplinary clinical background. As a respiratory therapist, he focused primarily on adult critical care, neonatal critical care, high-acuity transport, procedural care, outpatient care, and professional development. As a registered nurse, Paul’s clinical practice has been in the areas of medical/surgical care, orthopedics, perianesthesia care, invasive cardiology, care coordination, and nursing leadership. He has served as a course creator and instructor on various occasions over his years of practice. Paul has earned a Master of Science in Nursing in Nursing Informatics and is certified in Informatics Nursing by the ANCC. He is an active member of the Sigma Theta Tau International Honor Society of Nursing.
Access to over 1,450 courses! Access to 1,450+ courses for one low price.